Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2003
12/04/2003US20030223996 Analyzing the level of B lymphocte stimulator (BLyS) expression in a sample of an individual using antibodies, comparing the level of BLyS assayed in biological sample with a standard level of BLyS expresion in normal sample
12/04/2003US20030223983 Formulation comprising bioactive agents and method of using same
12/04/2003US20030223978 Conjugates of an AMF ligand and a cytotoxic molecule for use in cancer therapy
12/04/2003US20030223958 Use of interleukin-19 to treat ovarian cancer
12/04/2003US20030223957 Bioerodible (biodegradable) polymers to address fundamental needs in ocular surgery including sealants and sealing methods, barriers to cellular adhesion and proliferation, and mechanical barriers. The present invention is directed to
12/04/2003US20030223949 Use of a polypeptide for treatment of pruritus in animals
12/04/2003US20030223936 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/04/2003CA2513388A1 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
12/04/2003CA2487283A1 Method for assembling sub units into capsoides
12/04/2003CA2487153A1 New formulation for the parenteral application of crobenetine
12/04/2003CA2487150A1 New formulation for parental application of sodium channel blocker
12/04/2003CA2487117A1 Method for preparing polymer micelle pharmaceutical preparation containing drug for injection
12/04/2003CA2487070A1 Aqueous fludarabine phosphate composition
12/04/2003CA2486967A1 Cardiolipin compositions their methods of preparation and use
12/04/2003CA2486909A1 Compositions and method for transmucosal drug delivery and cryoprotection
12/04/2003CA2486613A1 Chewable compositions containing a gel-forming extract of psyllium
12/04/2003CA2486113A1 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2478833A1 Anti-.alpha.v.beta.6 antibodies
12/03/2003EP1366767A1 Aqueous suspension eyedrops and process for producing the same
12/03/2003EP1366762A1 Adhesive patch
12/03/2003EP1366760A1 Tablets quickly disintegrated in oral cavity
12/03/2003EP1366759A1 Tablets quickly disintegrating in oral cavity
12/03/2003EP1366455A2 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2003EP1366167A2 Biological organism for preparing pharmaceutical compositions for treating mammals
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1366064A1 Tumour targeting prodrugs activated by metallo matrixproteinases
12/03/2003EP1365813A2 Ascorbic acid analogs for metalloradiopharmaceuticals
12/03/2003EP1365812A2 Pharmaceutical composition having reduced tendency for drug crystallization
12/03/2003EP1365811A2 Compositions containing alpha-2-adrenergic agonist components
12/03/2003EP1365805A2 Novel targeted compositions for diagnostic and therapeutic use
12/03/2003EP1365803A2 Chemoprotectant for gastric toxicity
12/03/2003EP1365784A1 Methods and devices for tissue repair
12/03/2003EP1365781A1 Acrochordon alleviation
12/03/2003EP1365775A1 Telithromycin suspension with a masked taste
12/03/2003EP1365772A2 Stabilized brivudine topical formulations containing metal oxide pigments
12/03/2003EP1365764A1 Oral pharmaceutical composition of cefpodoxime proxetil
12/03/2003EP1365761A1 Therapeutic combination of amlodipine and benazepril
12/03/2003EP1365759A2 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
12/03/2003EP1365752A2 Methods for the treatment of a traumatic central nervous system injury with e.g. allopregnanolone
12/03/2003EP1365751A2 Granules and granules coated with a masked taste
12/03/2003EP1365749A2 Process for preparing pharmaceutical compositions for use with soft gelatin formulations
12/03/2003EP1365748A2 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release
12/03/2003EP1365747A1 Oral peptide pharmaceutical dosage form and method of production
12/03/2003EP1365746A1 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer
12/03/2003EP1365745A2 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
12/03/2003EP1365744A2 Method of producing porous tablets with improved dissolution properties
12/03/2003EP1365739A1 Composition for rectal delivery of an oxazolidinone antibacterial drug
12/03/2003EP1365737A2 Stable salts of o-acetylsalicyclic with basic amino acids
12/03/2003EP1365735A1 Water-in-oil emulsions containing one or more ammonium acryloyl dimethyltaurates or vinyl pyrrolidone copolymers
12/03/2003EP1365728A2 Anhydrous creams, lotions and gels
12/03/2003EP1365713A1 Urine incontinence device and corresponding method
12/03/2003EP1250125B1 Pharmaceutical compositions comprising terbinafine
12/03/2003EP1123301B1 Chelating agents for radioimmunotherapy
12/03/2003EP1053019B1 Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
12/03/2003EP1027037B1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
12/03/2003EP0975369B1 Polyethylene glycol-interferon alpha conjugates for therapy of infections
12/03/2003EP0973785B1 Trans-platinum compound, and diagnostic kit
12/03/2003EP0971702B1 Microgranules containing cisplatin
12/03/2003EP0874624B1 Hyaluronic acid receptors binding agents and their use for treating tumors or restenosis
12/03/2003EP0727982B1 Propylene glycol stearate vesicles
12/03/2003CN1460109A Improved specificity in treatment of diseases
12/03/2003CN1460100A Compounds and compositions for delivering active agents
12/03/2003CN1460026A Compositions containing alpha-2-adrenergic agonist components
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1460021A Plaster preparation
12/03/2003CN1460019A Improved injectable dispersions of propofol
12/03/2003CN1460018A Implantable gel compositions and method of mfg.
12/03/2003CN1460013A 局部凝胶给药体系 Topical gel delivery system
12/03/2003CN1459316A Plant substrates
12/03/2003CN1459315A Biodegradation type introducing agent of hardly water-soluble steroid, nonsteroid anti-inflammatory medicine, and its prepn. method
12/03/2003CN1129646C Anionic cationic polyion complexes comprising zwitterionic monomer component
12/03/2003CN1129427C TTS contg. antioxidant
12/03/2003CN1129424C Ceramide lipsome emulsion contaniing Va and its preparing process and usage
12/03/2003CA2409795A1 Liposome preparation
12/02/2003US6657050 Chimeric viral-neutralizing immunoglobulins
12/02/2003US6656970 Method and compositions for solubilization of pentacyclic triterpenes
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656922 Oral delivery of macromolecules
12/02/2003US6656921 Use of zinc hyaluronate for the prevention of reinfection after the healing of peptic ulcer by Helicobacter pylori
12/02/2003US6656917 Compositions and methods for targeted enzymatic release of cell regulatory compounds
12/02/2003US6656906 Hybrid polypeptides with enhanced pharmacokinetic properties
12/02/2003US6656734 Compositions for the delivery of polynucleotides to cells
12/02/2003US6656730 Attached to an arylpropionic acid that interacts with human serum albumin; acid is ibuprofen, suprofen, ketoprofen, (S)-(+)- pranoprofen, or carprofen.
12/02/2003US6656729 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003US6656508 Sustained-release alginate gels
12/02/2003US6656507 Aqueous dispersion suitable for the production of coatings and binders for solid oral drugs
12/02/2003US6656505 Method for forming an aqueous flocculated suspension
12/02/2003US6656504 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
12/02/2003US6656503 Counters ulcerogenic side effects; nonsteroidal antiinflam-matory core with polymer and misoprostol coating
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656471 Monitoring HLA-Cw7-restricted CTL response; AIDS prevention
12/02/2003US6656448 Matrix metalloproteinase inhibitors
12/02/2003US6656423 Sterile water generator
12/02/2003US6656385 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
12/02/2003CA2266484C Tablets containing a sweetening mixture
12/02/2003CA2132865C Transdermal administration of oxybutynin
12/02/2003CA2113901C Preparation of microparticles
11/2003
11/30/2003CA2388456A1 Macroaggregated albumin-polyethyleneimine (maa-pei) lung-targeted delivery of respiratory syncytial virus dna vaccines
1 ... 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 ... 1712